Telepathology Market Size - By Product (Scanner, Communication System, Storage System), By Application (Teleconsultation, Drug Discovery, Disease Diagnosis), By End-use (Hospitals, Academic & Research Institutes) – Global Forecast to 2032

Telepathology  Market Size

Telepathology Market size was valued at USD 656 million in 2022 and is estimated to account for USD 2.1 billion by 2032. Telepathology refers to the practice of remotely accessing and interpreting pathology images, such as in tissue diagnostics, using telecommunication technology.
 

It involves the digital capture and transmission of high-resolution images, enabling pathologists to review and diagnose cases from a distance. Telepathology facilitates consultation, second opinions, and collaboration among pathologists, overcoming geographical barriers and enhancing access to pathology expertise. Telepathology adopts artificial intelligence in medical imaging and thereby offers the potential for timely and accurate diagnosis, particularly in developing regions wherein physical access to pathology laboratory equipment and services is limited.
 

Additionally, increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes. For instance, as per the World Health Organization (WHO), there are approximately 41 million deaths due to non-communicable diseases (NCDs), annually, accounting for around 74% of total deaths. Furthermore, around 17 million individuals die prematurely from NCDs, with low- and middle-income countries bearing the brunt. Additionally, there is a growing recognition of the benefits associated with telehealth, including telepathology. Patients are becoming more aware of the convenience and accessibility offered by telemedicine, and healthcare providers are increasingly embracing teleconsultation as a means to expand their reach and improve patient care.
 

COVID-19 Impact

The COVID-19 pandemic significantly impacted the telepathology market. It led to increased adoption of telepathology services, ensuring continuity of pathology care while minimizing infection risks. Telepathology facilitated the diagnosis and triage of COVID-19 cases, enabled remote consultations and collaborations among pathologists, supported education and training programs. For instance, telepathology played a vital role in continuing education and training programs for pathologists during the pandemic. Virtual conferences, webinars, and online platforms allowed for knowledge sharing, case discussions, and skill development. The pandemic accelerated the acceptance and integration of telepathology into standard practices, with long-term implications for its continued utilization.
 

Telepathology Market Trends

The telepathology industry is witnessing significant research and development activities aimed at improving technology, enhancing image analysis algorithms, and integrating artificial intelligence (AI) capabilities. Researchers are continually working to develop advanced digital imaging systems, whole slide imaging system, and image analysis tools that offer higher resolution, improved image quality, and better accuracy in diagnosing various diseases. For instance, the NanoZoomer System was made by Hamamatsu to help pathologists in reviewing and interpreting digital pictures of surgical pathology slides made from formalin-fixed paraffin-embedded ("FFPE") tissue which is designed for in vitro diagnostic application. Additionally, increasing funding by public and private sector often aims to enhance telecommunication networks, expand access to digital pathology platforms, and promote collaboration between pathologists and telepathology service providers.
 

Telepathology Product Market Analysis

The telepathology market by product is categorized into scanner, communication system, and storage system. The scanner segment garnered USD 368.3 million revenue size in the year 2022. Scanners play a crucial role in telepathology by capturing high-resolution images of the specimens and transmitting them to pathologists for remote interpretation. Scanners, such as whole slide imaging (WSI) scanners, slide scanners, portable scanners, and microscopy systems including virtual microscopes. They enable the digitization of pathology specimens, facilitating remote access, efficient transmission, and collaborative diagnostics. Scanners enhance accessibility, workflow efficiency, and improve patient care outcomes in telepathology.
 

Based on application, the telepathology market is segmented into teleconsultation, drug discovery, disease diagnosis, and others. The teleconsultation segment is anticipated to witness high growth at 12.8% by 2032. Teleconsultation will drive the telepathology business by leveraging advanced technology to remotely review and diagnose digital pathology images. It will also help to overcome geographical barriers, ensuring access to specialized expertise for healthcare professionals in remote areas.
 

Furthermore, the World Health Organization (WHO) recommended telemedicine and digital interventions to strengthen health systems. In 2020, Digital Implementation Investment Guide (DIIG) provided guidance on integrating digital interventions, while, in 2021, Global Strategy promoted their responsible adoption. These initiatives reflected WHO's commitment to leveraging telemedicine and digital health for stronger healthcare systems. Overall, teleconsultation will optimize workflow, manage higher case volumes, and address healthcare disparities, providing equitable access to pathology services.
 

The telepathology market by end-use is segregated into hospitals, academic & research institutes, and others. The hospitals segment accounted for over 54.7% industry share in the year 2022. The predominant presence of hospitals is driven by the demand for remote pathology expertise, seamless collaboration, and workflow optimization. These factors collectively contribute to improved patient care, enhanced diagnostics, and the overall gains of the industry within the hospital sector. Furthermore, the increasing incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has led to a higher demand for pathology services in hospitals. This capability significantly enhances the management and treatment of these conditions within the hospital setting. These factors collectively contribute to improved patient care, enhanced diagnostic capabilities.
 

U.S. telepathology market accounted for USD 247.8 million revenue size in 2022. The telepathology industry in the U.S. is the increasing demand for efficient and timely pathology services. Additionally, the rapid advancement of digital imaging and communication technologies serves as a propelling factor for business in the U.S. For instance, digital pathology platforms and high-resolution imaging systems have become more accessible and user-friendly, allowing pathologists to capture and share high-quality images of tissue sample these images can be easily transmitted to remote experts for consultation and second opinions, enabling pathologists to tap into a wider network of expertise. These driving forces are reshaping the field of pathology, enabling pathologists to collaborate remotely, improve diagnostic accuracy, and deliver enhanced patient care.
 

Telepathology Market Share

Some of the eminent industry participants operating in the telepathology market include :

• Cerner Corporation
• GlobalMedia Group LLC
• Medtronic plc.
• InTouch Health
• American Well
• Vidyo, Inc.
• Care Innovations
• Cisco Systems, Inc.
• Aerotel Medical Systems Ltd.
• Honeywell Life Care Solutions
• Medvivo Group Ltd.
• AMD Global Telemedicine, Inc.
• Koninklijke Philips N.V.
• unstall Healthcare.
   

Telepathology Industry News:

• In February 2022, GlobalMedia Group, LLC revealed that it obtained the CE mark for, ClinicalAccess Station Lite, eNcounter telehealth software suite and various diagnostic examination cameras. This regulatory approval enabled the company to extend its services to the European Union, expanding its reach and offering telehealth solutions in European markets.
   

Telepathology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product (USD Million & Units)

• Scanner
• Communication system
• Storage system

By Application (USD Million)

• Teleconsultation
• Drug discovery
• Disease diagnosis
• Others

By End-use (USD Million)

• Hospitals
• Academic and research institutes
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey